Disorders with Malignant Potential

Disorders with Malignant Potential
Lawrence Eichenfield M.D.
Clinical Pearls
(LE)
Basal Cell Nevus Syndrome
Synonym
Nevoid basal cell carcinoma syndrome
Gorlin syndrome
Inheritance
Autosomal dominant; PTCH1 (PATCHED1) gene on 9q22-31
Prenatal Diagnosis
DNA mutation analysis
Incidence
Approximately 1:60,000; M=F
Age at Presentation
Birth (bossing, skeletal anomalies); childhood (jaw cysts, basal cell carcinoma)
Pathogenesis
Mutations in PTCH1, a tumor suppressor gene encoding the sonic hedgehog transmembrane receptor protein; receptor interacts with signaling proteins important for controlling cell fate, patterning, and growth
Key Features
Skin
Basal cell carcinomas (BCCs)—multiple, skin-colored to tan, dome-shaped papules on face, neck, trunk
Palmoplantar pits—2- to 3-mm erythematous pits, rarely develop into BCCs; milium, epidermoid cysts
Musculoskeletal
Jaw cysts (odontogenic keratocysts)—secondary pain, swelling, drainage, increased in molar and premolar areas in maxilla, usually multiple, lining with malignant potential
Frontal bossing, bifid ribs, vertebral fusion, kyphoscoliosis
Central Nervous System
Calcification of falx cerebri, agenesis of corpus callosum, medulloblastoma, mental retardation (less common)
Eyes
Hypertelorism, congenital blindness, cataracts, colobomas, strabismus
Genitourinary
Ovarian fibromas, fibrosarcoma
Differential Diagnosis
Bazex syndrome
Unilateral linear nevoid basal cell carcinomas
Melanocytic nevi
Rombo syndrome
Xeroderma pigmentosa (XP) (p. 174)
Laboratory Data
Skin biopsy
Skeletal surveys of skull, maxilla, mandible, ribs, vertebrae
Management
Referral to dentist/oral surgeon
Referral to dermatologist/Moh’s surgeon—surgical excision, electrodesiccation and curettage with/without general anesthesia, topical 5-fluorouracil, imiquimod; frequent cutaneous examinations
Oral retinoids—suppression of new BCCs
Avoid radiotherapy/x-rays—induces new BCCs
Sun avoidance, broad-spectrum sunscreen, protective clothing
Referral to orthopedist, neurologist, ophthalmologist
Prognosis
Normal life span if BCCs treated early on and no other malignancies develop; close surveillance with physician throughout life; disfiguring scars may create psychosocial problems
5.1. Pigmented facial basal cell carcinomas with post-surgical scars and glabellar graft. (5)
5.2. Multiple tan-brown basal cell carcinomas on patient’s back. (5)
5.3. Large jaw cysts in maxilla and mandible. (5)

image

Xeroderma Pigmentosum
Inheritance
Autosomal recessive
XPA gene encodes DNA damage binding protein 1 (DDB1) gene on 9q22
XPB gene encodes excision-repair cross-complementing 3 (ERCC3) gene on 2q21
XPC gene encodes endonuclease on 3p25
XPD gene encodes ERCC2 on 19q13
XPE gene encodes DDB2 on 11p12
XPF gene encodes ERCC4 on 16p13
XPG gene encodes endonuclease on 13q33
XPV (Variant) gene encodes polymerase η on 6p21
Prenatal Diagnosis
DNA analysis
UDS (unscheduled DNA synthesis) assay on cultured amniotic fluid cells
Incidence
1:1,000,000 in the United States; 1:40,000 in Japan; M=F
XPA, C, and V comprise 75% of all patients
XPA—most common form in Japan, over 90% with identical single base substitution mutation; skin with mild-severe neurologic manifestations
XPB—rare in the United States; skin and neurologic; association with Cockayne syndrome, trichothiodystrophy
XPC—most common form in the United States, rare in Japan; skin without neurologic manifestations
XPD—moderate frequency; association with trichothiodystrophy and XP-Cockayne complex, skin and neurologic manifestations
XPE—rare; mild skin without neurologic manifestations
XPF—moderate rare; most seen in Japan; skin without neurologic manifestations
XPG—extremely rare; association with Cockayne, skin with Cockayne-like neurologic manifestations
XPV—approximately 30% of all cases; United States, Europe, Japan; mild-severe skin without neurologic manifestations
Age of Presentation
First few years of life
Pathogenesis
Mutations in genes encoding DNA repair enzymes (DNA helicase, endonuclease, or DNA damage-binding protein) leads to defective DNA excision repair upon exposure to ultraviolet radiation; defective postreplication repair in XPV group
Complementation groups (total of 8), based on correction of reduced post-UV UDS after fusion of skin fibroblasts from two different patients, have distinct clinical characteristics, frequency and distribution
Key Features
Skin (severity may vary with different complementation groups)
Infancy
Acute sun sensitivity with sunburn-like reaction (erythema, inflammation, bullae)
First Years of Life
Childhood/adolescence (listed in order of appearance)—pigmented macules, achromic macules, and telangiectasias in photodistribution; dry, scaly, atrophic, with narrowing of mouth and nares; actinic keratoses, keratoacanthomas; 1,000-fold increased risk for basal cell carcinoma, squamous cell carcinoma, malignant melanoma
Eyes
Progressive symptomatology with photophobia, conjunctivitis, telangiectasia and pigmentation of lid and conjunctiva; ectropion, corneal vascularization, opacification; benign lid papillomas; BCC, malignant melanoma
Neurologic (20% of cases—most in XPA and XPD)
Progressive neurologic degeneration with mental retardation, sensorineural deafness; with/without microcephaly, hyporeflexia, spasticity, ataxia
Differential Diagnosis
Infancy/Early Childhood
Erythropoietic protoporphyria (p. 224)
Congenital erythropoietic porphyria (p. 226)
Bloom syndrome (p. 234)
Cockayne syndrome (p. 242)
Hartnup disease (p. 250)
Rothmund-Thomson syndrome (p. 238)
Laboratory Data
DNA analysis
UDS assay from cultured skin fibroblasts
Management
Referral to dermatologist—sun avoidance/limit outdoor activity to early morning, late afternoon and night; photoprotect with physical block sunscreen, long-sleeve, long pants, frogskin clothing, wide-brimmed hat, UV-blocking glasses with side shields, long hair styles
Dermatologic cancer screening every 3 months with weekly examination by informed parent
Removal of cutaneous neoplasms, cryotherapy, 5-fluorouracil, imiquimod Isotretinoin—prevention of new skin cancers
Referral to ophthalmologist—corneal protection with methylcellulose drops, soft contact lens; corneal transplantation, regular cancer screening
Referral to neurologist if symptomatic
Referral to XP support group
Prognosis
Early diagnosis with UV protection and close malignancy surveillance will prevent skin cancers; otherwise premature death at early age; UV exposure prior to diagnosis and protection may induce neoplasm; neurologic symptoms are progressive and unaffected by UV protection; severe psychosocial impact
5.4. Photodistributed bullae, erythema, and inflammation in girl with XP. Note sharp cut-off of eruption on exposed neck. (66)
5.5. Destructive cutaneous carcinomas and squamous cell carcinoma of the tongue in this unfortunate terminal boy. (20)
5.6. Iris melanoma and blood obliterate the anterior chamber of the eye. (67)

image

Muir-Torre Syndrome
Synonym
Torre syndrome
Torre-Muir syndrome
Inheritance
Autosomal dominant; MSH1 and MSH2 genes on 3p21 and 2p22-21, respectively
Prenatal Diagnosis
DNA analysis
Incidence
At least 65 cases reported; M=F
Age of Presentation
Fifth to sixth decade of life (internal malignancies usually precede cutaneous lesions)
Pathogenesis
Mutations in MSH2 (most common) and MSH1, DNA mismatch repair genes, produces phenotype; syndrome is linked to the Lynch II cancer family syndrome
Key Features
Skin
Multiple sebaceous tumors: adenomas (most common), carcinomas, hyperplasias, epitheliomas, basal cell carcinoma with sebaceous differentiation Keratoacanthomas
Neoplasms
Adenocarcinoma of the colon (most common), other gastrointestinal tract, genitourinary tract, lung, breast, and hematologic malignancies described
Differential Diagnosis
Cowden syndrome (p. 188)
Gardner syndrome (p. 184)
Laboratory Data
Skin biopsy
Endoscopy/gastrointestinal x-ray
Management
Close follow-up by internist screening for malignancy
Referral to dermatologist
Referral to gastroenterologist
Prognosis
Malignancies usually low-grade with good prognosis; may have normal life span with close surveillance and early detection of malignancy

image

5.7. Multiple sebaceous hyperplasia and sebaceous adenomas on patient’s forehead. (68)
5.8. Sebaceous carcinoma of upper eyelid. (69)
Dyskeratosis Congenita
Synonym
Zinsser-Engman-Cole syndrome
Inheritance
X-linked recessive (most common); dyskerin (DKC1) gene on Xq28; autosomal dominant and recessive patterns have been described; telomerase RNA component (TERC) gene on 3q21-q28 in autosomal dominant cases
Prenatal Diagnosis
DNA analysis
Incidence
Over 100 cases reported; M:F=10:1
Age at Presentation
First decade of life (cutaneous, nail, mucosal changes)
Pathogenesis
Mutation in the DKC1 gene encoding the dyskerin protein has untoward effects on RNA nucleolar function and RNA telomerase activity with subsequent problems in cell proliferation in blood and epithelium; TERC gene mutations responsible for the RNA component of telomerase, has been implicated in autosomal dominant cases
Key Features
Skin
Reticulated gray-brown hyperpigmentation on neck, face, trunk, upper thighs; atrophy, hypopigmentation, and telangiectasias within pigmentation Palmoplantar hyperkeratosis, hyperhidrosis, friction bullae, acrocyanosis
Hair
Thinning alopecia on scalp, eyebrows, eyelashes
Nails
Dystrophic with longitudinal ridges, pterygium; atrophic, or absent
Mouth
Premalignant leukoplakia of the tongue, buccal mucosa, pharynx; dental caries with early loss of teeth
Mucous Membranes
Premalignant leukoplakia of any mucosal surface
Hematologic
Fanconi’s type pancytopenia with secondary infection, hemorrhage
Eyes
Blepharitis, conjunctivitis, lacrimal duct obstruction with epiphora, ectropion
Central Nervous System
Mild to moderate mental retardation (50%)
Differential Diagnosis
Fanconi syndrome
Pachyonychia congenita (p. 294)
Rothmund-Thomson syndrome (p. 238)
Chronic graft vs. host disease
Laboratory Data
Mucosal biopsy
Bone marrow biopsy
DNA analysis
Management
Referral to hematologist/oncologist—bone marrow transplantation, transfusions, oral retinoids
Referral to dermatologist, otolaryngologist, gastroenterologist, ophthalmologist
Counsel against excessive sun exposure, smoking
Prognosis
Death usually in 20s to 30s secondary to malignancy (usually squamous cell carcinoma), gastrointestinal hemorrhage, or opportunistic infection
5.9. Poikilodermatous changes in the axilla extending on to arm. (1)
5.10. Dystrophic and absent nails. (1)
5.11. Premalignant leukoplakia of the buccal mucosa. (70)

image

Gardner Syndrome
Inheritance
Autosomal dominant; adenomatous polyposis coli (APC) gene on 5q21-22
Prenatal Diagnosis
DNA analysis
Incidence
Approximately 1:14,000; M=F
Age at Presentation
Infancy to early childhood (bone, skin lesions); second to fourth decade (gastrointestinal lesions)
Pathogenesis
Mutations in APC, a tumor suppressor gene that regulates B-catenin, an adherens junction protein controlling cell growth and early embryonic axis formation, promotes tumor formation; high dietary fat may play a role in patients with the genetic defect
Key Features
Skin
Epidermoid cysts—increased on head and neck; may have unusual location on toe, scalp, shin
Fibromas
Musculoskeletal
Osteomas—maxilla, mandible, other skull bones; small, multiple
Gastrointestinal
Polyposis with high predisposition to malignant adenocarcinoma; most common in colon/rectum
Desmoid tumors—postabdominal surgery; uteral or intestinal obstruction
Eyes
Congenital hypertrophy of retinal pigment epithelium (CHRPE)—congenital marker for diagnosis
Teeth
Odontomas, supernumerary teeth
Jun 25, 2016 | Posted by in Dermatology | Comments Off on Disorders with Malignant Potential

Full access? Get Clinical Tree

Get Clinical Tree app for offline access